Advanced-stage renal cell carcinoma treated by radical nephrectomy and adjacent organ or structure resection

BJU International

Volumn 103, Issue 2, 2009, Pages 160-164

  Karellas, Michael E ^a   Jang, Thomas L ^a   Kagiwada, Megan A ^a   Kinnaman, Michael D ^a   Jarnagin, William R ^a   Russo, Paul ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adjacent organ resection; Advanced local renal cell cancer; Renal cell carcinoma

Indexed keywords

INTERFERON; INTERLEUKIN 2; RETINOIC ACID; SORAFENIB; SURAMIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; MALE; NEPHRECTOMY; PRIORITY JOURNAL; TUMOR VOLUME;

AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 58149154801     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08025.x     Document Type: Article

References (21)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008 58 : 71 96
2. Russo P, Synder M, Vickers A, Kondagunta V, Motzer R. Cytoreductive nephrectomy and nephrectomy/complete metastasectomy for metastatic renal cancer. Sci World J 2007 7 : 768 78
3. Tamaskar I, Garcia JA, Elson P et al. Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy. J Urol 2008 179 : 81 6
4. Motzer RJ, Michaelson MD, Rosenberg J et al. Sunitinib efficacy against advanced renal cell carcinoma. J Urol 2007 178 : 1883 7
5. Flanigan RC, Mickisch G, Sylvester R, Tangen C, Van Poppel H, Crawford ED. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol 2004 171 : 1071 6
6. Flanigan RC, Salmon SE, Blumenstein BA et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001 345 : 1655 9
7. Mickisch GH, Garin A, van Poppel H, de Prijck L, Sylvester R. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 2001 358 : 966 70
8. Greene FL. The American Joint Committee on Cancer: updating the strategies in cancer staging. Bull Am Coll Surg 2002 87 : 13 5
9. Eble JN, Epstein JI, Sesterhenn IA. Pathology and Genetics. Tumors of the Urinary System and Male Genital Organs. Lyon : IARC Press, 2004
10. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 1971 28 : 1165 77
11. Karakiewicz PI, Lewinshtein DJ, Chun FK et al. Tumor size improves the accuracy of TNM predictions in patients with renal cancer. Eur Urol 2006 50 : 521 8
12. Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med 1996 335 : 865 75
13. Bromwich E, Hendry D, Aitchison M. Cytoreductive nephrectomy: is it a realistic option in patients with renal cancer? BJU Int 2002 89 : 523 5
14. Eggener SE, Yossepowitch O, Pettus JA, Snyder ME, Motzer RJ, Russo P. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. J Clin Oncol 2006 24 : 3101 6
15. Russo P. Genitourinary oncology. In Vogelzang N, Open Radical Nephrectomy for Localized Renal Cell Carcinoma, 3rd edn. Philadelphia, PA : Lipincott, Williams & Wilkins, 2006 : 725 31
16. Margulis V, Sanchez-Ortiz RF, Tamboli P, Cohen DD, Swanson DA, Wood CG. Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management. Cancer 2007 109 : 2025 30
17. Sorbellini M, Kattan MW, Snyder ME et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 2005 173 : 48 51
18. Lam JS, Belldegrun AS, Pantuck AJ. Long-term outcomes of the surgical management of renal cell carcinoma. World J Urol 2006 24 : 255 66
19. O'Brien MF, Russo P, Motzer RJ. Sunitinib therapy in renal cell carcinoma. BJU Int 2008 101 : 1339 42
20. Motzer RJ, Rini BI, Bukowski RM et al. Sunitinib in patients with metastatic renal cell carcinoma. JAMA 2006 295 : 2516 24
21. Ratain MJ, Eisen T, Stadler WM et al. Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. J Clin Oncol 2006 24 : 2505 12